GSK Reviews Options For European Business, Adopts New Manufacturing Processes

06 Feb 2013

• By John Davis

GlaxoSmithKline will implement a new £1.5 billion restructuring program to improve commercial efficiencies in Europe and adopt new manufacturing processes, following sales and profits shortfalls in 2012.

GSK Reviews Options For European Business, Adopts New Manufacturing Processes

More from Archive

More from Pink Sheet